Jain told CNBC-TV18, "In Sun Pharma Advanced Research I think consolidation a little bit more is required because a pattern is a little more volatile than what one would expect in something which is making a breakout, so it has made a breakout, it has come down, consolidating."
She further added, "I think one should keep a stoploss of Rs 94.65 odd and then probably see if it can cross Rs 104 odd levels. I think it is positive but a little more consolidation is required. So may take a little more time before breakout. So I would watch that Rs 104 level very effectively. If that gets crossed then probably a big move is on the cards."
At 13:22 hrs the share was quoting at Rs 96.80, up Rs 1.35, or 1.41% with volumes of 340,281 shares. Market capitalisation stands at Rs 2,004.89 crore.
The company touched its 52 week high Rs 104.30 and 52 week low Rs 44.50 on 25 Mar, 2010 and 26 Mar, 2009, respectively. Currently, it is trading -7.19% below its 52-week high and 117.53% above its 52-week low.
The company's trailing 12-month (TTM) EPS was at Rs 0.08 per share. The stock's price-to-earnings (P/E) ratio was 1,210.00. The latest book value of the company is Rs 1.72 per share. At current value, the price-to-book value of the company was 56.28.
